The biomarker with the most robust association with subclinical carotid atherosclerosis in the present study, based on magnitude, consistency of associations regardless of HIV serostatus, and coherence across carotid measures, was CCL2. The gene discussed is CCL2; the disease is carotid atherosclerosis.